Canada markets close in 2 hours 45 minutes

Canntab Therapeutics Limited (TBF1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.4160+0.0100 (+2.46%)
As of 8:03AM CET. Market open.
Full screen
Previous Close0.4060
Open0.4160
Bid0.4380 x 0
Ask0.4780 x 0
Day's Range0.4160 - 0.4160
52 Week Range0.1590 - 0.7150
Volume5
Avg. Volume48
Market Cap14.636M
Beta (5Y Monthly)1.35
PE Ratio (TTM)N/A
EPS (TTM)-0.0870
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    COVID-19 Pandemic - The government presents its daily update

    QUÉBEC CITY, Nov. 28, 2020 /CNW Telbec/ - The most recent data on the evolution of COVID-19 in Québec show 1,480 new cases, bringing the total number of people infected to 139,643.

  • Canntab Therapeutics Announces End of Supply and Distribution Agreements with Exactus
    Newsfile

    Canntab Therapeutics Announces End of Supply and Distribution Agreements with Exactus

    Toronto, Ontario--(Newsfile Corp. - November 16, 2020) -  Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announces that Canntab and Exactus, Inc. have mutually agreed to terminate the supply and distribution agreements previously announced on November 20, 2019, after determining that the regulatory requirements could not be completed on a timely basis.During a time ...

  • Newsfile

    Canntab Announces Closing of Purchases of Cannabis Processing Equipment and Leasehold Improvements

    Toronto, Ontario--(Newsfile Corp. - October 19, 2020) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that the previously announced asset purchase agreement with CMAX Technologies Inc. ("CMAX"), a related party of the Company has closed (the "CMAX Transaction"). Pursuant to the CMAX Transaction, Canntab has acquired certain cannabis-processing ...